New Delhi : In a historic leap for India’s biotechnology and cancer care landscape, Prime Minister Narendra Modi today unveiled the country’s first indigenous CAR-T Cell Therapy — NexCAR19 , developed by ImmunoACT, an IIT Bombay spin-off. The innovation, supported by the Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC), was presented during the Emerging Science, Technology & Innovation Conclave (ESTIC) 2025 in Delhi.

The Prime Minister presented three transformative innovations to the nation — QSIP, India’s own quantum security chip; 25-qubit QPU, India’s first quantum computing chip; and NexCAR19, the country’s first indigenous CAR-T cell therapy. Among these, NexCAR19 stands out as the world’s first humanised CAR-T therapy developed

See Full Page